Actavia Life Sciences, Inc. (RASP)
OTCMKTS · Delayed Price · Currency is USD
0.0005
+0.000499 (49,900.00%)
At close: Dec 26, 2025
Actavia Life Sciences Market Cap
Actavia Life Sciences has a market cap or net worth of $385.91 thousand as of October 20, 2026. It is the 50,556th most valuable company in the world and the 7,000th biggest in the United States. Its market cap has decreased by 87.50% in one year.
Market Cap
385.91K
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#7,000 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since October 14, 2016, Actavia Life Sciences's market cap has decreased from 71.15M to 385.91K, a decrease of -99.46%. That is a compound annual growth rate of -43.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2025 | 385.91K | -83.28% |
| Dec 14, 2021 | 2.31M | -33.00% |
| Dec 31, 2020 | 3.45M | -90.74% |
| Dec 13, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 1, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 14, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Regenerative Medical Technology Group | 562.46K |
| Altamira Therapeutics | 514.39K |
| Neon Bloom | 488.20K |
| CERo Therapeutics Holdings | 455.53K |
| Orgenesis | 431.18K |
| Lyra Therapeutics | 337.23K |
| THC Farmaceuticals | 320.93K |
| MetaStat | 319.73K |